CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

MACLEODS PHARMA USA, INC recalls Olmesartan Medoxomil

Read the official FDA notice

Published
4 Nov 2026
Units affected
3528 30-count and 216 90-count bottles
Agency
FDA
Country
United States

The hazard

Failed Dissolution Specifications.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg, packaged as a) 30-count bottle, NDC 33342-246-07; b) 90-count bottle, NDC 33342-246-10; Rx Only, Manufactured for : Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd, Daman, 396210, India

Brand / company
MACLEODS PHARMA USA, INC
Codes / lots
Lot #: a) 12251163A, Exp 05-31-2027; b) 12251163B, Exp 05-31-2027
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 4 Nov 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.